<DOC>
	<DOCNO>NCT00142740</DOCNO>
	<brief_summary>This laboratory-based substudy effectiveness trial two Hepatitis B vaccines HIV-negative youth do evaluate genetic contribution individualize immune response .</brief_summary>
	<brief_title>Hepatitis B Vaccine Genetics : A Substudy ATN 024 ATN 025</brief_title>
	<detailed_description>This laboratory-based substudy ATN 024 025 evaluate genetic contribution highly individualize immune response hepatitis B vaccine individual confirm correlation specific human leukocyte antigen ( HLA ) alleles haplotype Hepatitis B Virus ( HVB ) antibody concentration antibody decay kinetics vaccinate adolescent . Approximately 5 ml whole blood collect study participant time week 28 visit subsequent study visit clinic visit follow successful completion week 28 visit . Peripheral blood mononuclear cell obtain QIA amp Blood kit use extract high-quality genomic DNA polymerase chain reaction-based genotyping PEII laboratory . The study expect available duration parent study approximately 2 year . This study require one visit may arrange coincide study routine clinic visit . There follow visit .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects currently enrol ATN 024 ATN 025 eligible enrollment ATN 052 begin follow completion week 28 visit . Subjects previously enrol ATN 024 ATN 025 eligible enrollment ATN 052 , unless subject prematurely discontinue study prior first postvaccination serology assessment perform week 28 . Current pregnancy permit . A sign informed assent/consent must obtain subject . Written parental guardian permission must obtain required institutional review board/ethics committee ( IRB/EC ) . Inadequate postvaccination serology evaluation ATN 024 ATN 025 . Unable obtain informed consent and/or parental/legal guardian permission require local IRB/EC .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Hepatitis B vaccine</keyword>
	<keyword>HIV-infected adolescent</keyword>
	<keyword>Hepatitis B infection ( negative )</keyword>
	<keyword>HIV vaccine trial</keyword>
</DOC>